In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Reconsidering Drug Chains' Divestiture Strategies - Commission's Balto

This article was originally published in The Rose Sheet

Executive Summary

The Federal Trade Commission is reconsidering its traditional strategy of requiring the divestiture of store locations before approving drug chain mergers, FTC Bureau of Competition Office of Policy and Evaluation Assistant Director David Balto told the National Association of Chain Drug Stores Aug. 31.
Advertisement

Related Content

FTC Public Workshop On Retail Slotting Issues Urged By Senate Committee
FTC Public Workshop On Retail Slotting Issues Urged By Senate Committee
Advertisement
UsernamePublicRestriction

Register

RS007100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel